文献速递前列腺癌

经腹膜前入路、保留Retzius间隙、腹膜外、经膀胱和经会阴入路对机器人辅助根治性前列腺切除术后尿控恢复的影响:比较研究的系统评价与Meta分析

Impact of transperitoneal anterior, retzius-sparing, extraperitoneal, transvesical and perineal approaches on urinary continence recovery after robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2025-02-10

该系统评价与Meta分析比较了机器人辅助根治性前列腺切除术(RARP)不同入路对尿控恢复的影响。保留Retzius间隙(RS)入路在多个随访时间点的尿控率均优于经腹膜前入路,但随机对照试验亚组分析显示6个月和12个月时两种入路尿控率重叠。腹膜外与经腹膜前入路、单孔与多孔RARP的6个月尿控率相当。

要点

  • RS-RARP在即刻、1、3、6、12个月尿控率均显著优于经腹膜前RARP。
  • 随机对照试验亚组分析中,RS与经腹膜前入路6个月和12个月尿控率无显著差异。
  • 腹膜外与经腹膜前入路、单孔与多孔RARP的6个月尿控率相当。

核心结论

  • 在主要为低至中等质量证据的局限性下,对于多孔RARP患者,RS入路在不同随访时间点的尿控恢复方面较经腹膜前入路具有显著优势。
  • 多孔经会阴和经膀胱入路需进一步验证,可能在单孔RARP setting中有意义。
  • Meta分析显示单孔与多孔RARP在尿控率方面结果相当。

研究设计与样本

  • 系统评价与Meta分析,纳入近十年发表的英文比较研究,仅纳入报告不同随访时间点尿控率的研究。
  • 从每个合格研究中提取分析患者数、研究设计、尿控定义以及可获得的即刻、1、3、6、12个月尿控率。
  • 统计分析使用RevMan 5.4,计算比值比(OR)及95%置信区间(CI),采用通用逆方差法,显著性水平设为p<0.05。

主要发现

  • 比较经腹膜前RARP与RS-RARP的研究Meta分析显示,尿控率在即刻(OR=3.73;95%CI:2.17-6.43;p<0.0001)、1个月(OR=4.16;95%CI:2.68-6.48;p<0.00001)、3个月(OR=4.71;95%CI:3.70-6.00;p<0.0001)、6个月(OR=4.12;95%CI:2.95-5.75;p<0.00001)和12个月(OR=3.25;95%CI:1.76-5.99;p<0.00001)均显示RS入路具有统计学显著优势。
  • 随机对照试验亚组分析显示,两种入路术后6个月(OR=1.99;95%CI:0.90-4.42;p=0.09)和12个月(OR=1.36;95%CI:0.43-4.31;p=0.60)尿控率重叠。
  • 比较腹膜外与经腹膜前入路的研究Meta分析显示,6个月尿控率在两种入路间重叠(OR=1.18;95%CI:0.85-1.65;p=0.32)。
  • 比较单孔(SP)与多孔(MP)RARP的研究Meta分析显示,6个月尿控率相当(OR=0.93;95%CI:0.65-1.33;p=0.69)。

临床怎么用

  • 原文结论指出,在多孔RARP患者中,RS入路较经腹膜前入路在尿控恢复方面具有显著优势。
  • 原文结论指出,多孔经会阴和经膀胱入路需进一步验证,可能在单孔RARP setting中有意义。
  • 原文结论指出,单孔与多孔RARP在尿控率方面结果相当。

局限性

  • 证据质量主要为低至中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Urinary incontinence significantly impacts on health-related quality of life of patients undergoing radical prostatectomy. In the last decades, several approaches (extraperitoneal, Retzius-sparing (RS), perineal and, transvesical) for robot-assisted radical prostatectomy (RARP) have proposed with the aim to improve functional outcomes in comparison with transperitoneal, anterior ones. METHODS: We performed a systematic review and meta-analysis of studies published in English language, in the last ten years, comparing the different approaches used to perform RARP. We included only studies reporting urinary continence rates at different follow-up time points. From each eligible study, we extracted the number of analyzed patients; the study design; the continence definition; and, when available, immediate, 1-, 3-, 6-, and 12-mo urinary continence rates. Statistical analyses were performed using RevMan version 5.4 (Cochrane Collaboration, Oxford, United Kingdom, UK). The Odds Ratio (OR) with 95% confidence intervals (CIs) was calculated using the generic inverse variance. A p value of <0.05 was set as significance level when comparing studies. RESULTS: The meta-analyses of studies comparing anterior, transperitoneal RARP and RS-RARP in terms of immediate (OR = 3.73; 95% CI: 2.17-6.43; p < 0.0001), 1-mo (OR = 4.16; 95% CI: 2.68-6.48; p < 0.00001), 3-mo (OR 4.71; 95% CI: 3.70-6.00; p < 0.0001), 6-mo (OR 4.12; 95% CI: 2.95-5.75; p < 0.00001) and 12-mo (OR = 3.25; 95% CI: 1.76-5.99; p < 0.00001) urinary continence rates showed a statistically significant advantage in favor of RS approach. However, a sub-analysis of Randomized Controlled Trials showed overlapping urinary continence rates between the two approaches at 6-mo (OR = 1.99; 95% CI: 0.90-4.42; p = 0.09) and 12-mo (OR = 1.36; 95% CI: 0.43-4.31; p = 0.60) after surgery. The meta-analysis of studies comparing extraperitoneal and transperitoneal approaches showed that 6-mo urinary continence rates were overlapping between the two approaches (OR = 1.18; 95% CI: 0.85-1.65; p = 0.32). The meta-analysis of studies comparing single-port (SP) and multi-port (MP) RARP showed comparable 6-mo urinary continence rates (OR = 0.93; 95% CI 0.65-1.33; p = 0.69). CONCLUSIONS: Within the limitations of mainly low to moderate quality of evidence, the RS approach offers significant advantages compared to an anterior, transperitoneal, approach in terms of urinary continence recovery at different follow-up time points in patients who underwent MP-RARP. MP perineal and transvesical approaches need to be further tested and might be of interest in the setting of SP-RARP. Our meta-analysis showed comparable results between SP- and MP-RARP in terms of urinary continence rates.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Ficarra V, Rossanese M, Ilaria R, et al. Impact of transperitoneal anterior, retzius-sparing, extraperitoneal, transvesical and perineal approaches on urinary continence recovery after robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies. Prostate Cancer Prostatic Dis. 2025. PMID: 39929994. doi:10.1038/s41391-025-00943-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。